Craft

Shanghai Henlius Biotech

Total Funding

$346 M

Shanghai Henlius Biotech Summary

Company Summary

Overview
Shanghai Henlius Biotech provides clinical-stage biopharmaceutical services. The company focuses on the development, production, and commercialization of mAb (monoclonal antibody) biosimilar drugs, bio-betters, and mAbs. Its products in development cover a variety of therapeutic areas including oncology and autoimmune diseases.
Type
Private
Status
Active
Founded
2009
Website
http://www.henlius.com/en/
Cybersecurity rating
Sectors

Table of Contents

Footer menu